Deaths from rectal cancer are rising rapidly among younger adults in the United States, according to recent research presented at Digestive Disease Week 2026. The trend is particularly pronounced among millennials, with mortality rates increasing faster than those for colon cancer in the same age group. This alarming pattern has prompted concern among gastroenterologists and public health officials who are working to understand the underlying causes.
A study led by Mythili Menon Pathiyil, a gastroenterology fellow at SUNY Upstate Medical University in Syracuse, Novel York, found that rectal cancer deaths are rising two to three times faster than colon cancer deaths in adults under 50. If current trends continue, rectal cancer mortality could surpass colon cancer deaths in this demographic by 2035. Colon cancer remains the leading cause of cancer death among people under age 50 in the U.S., making this shift especially significant.
The American Cancer Society projects that 158,850 new colorectal cancer cases will be diagnosed in the United States in 2026, with approximately 55,230 deaths attributed to the disease. Nearly one-third of these deaths are expected to occur in individuals under age 65. While colorectal cancer rates have been increasing by about 3% annually among adults under 50 since the late 1990s, the rise in rectal cancer specifically is driving a disproportionate share of this increase among younger populations.
Dr. Ben Schlechter, a gastrointestinal medical oncologist at Dana-Farber Cancer Institute in Boston, described the trend as a “medical crisis” that should not be ignored. He emphasized that the rapid increase in rectal cancer incidence and mortality among millennials and Generation Z warrants urgent investigation into potential environmental, lifestyle, or biological factors contributing to the shift.
The research, which has not yet been published in a peer-reviewed journal, builds on earlier findings from the American Cancer Society released in March 2026. That study showed that rising rectal cancer rates are a primary driver behind increased colorectal cancer diagnoses in people younger than 65. Scientists note that while colon and rectal cancers are similar diseases, they originate in different parts of the digestive tract and may have distinct risk profiles.
Understanding the Rise in Early-Onset Rectal Cancer
Experts are investigating several hypotheses to explain why rectal cancer is affecting younger adults at increasing rates. Potential factors under study include changes in gut microbiome composition, dietary habits such as increased consumption of processed foods, sedentary lifestyles, and rising obesity rates. Yet, no single cause has been identified, and researchers stress that the phenomenon likely results from a combination of influences rather than one definitive trigger.
Unlike traditional colorectal cancer screening guidelines, which recommend beginning colonoscopies at age 45 for average-risk individuals, many young patients are presenting with advanced symptoms before they qualify for routine screening. Common signs include rectal bleeding, changes in bowel habits, unexplained weight loss, and persistent abdominal discomfort—symptoms that are sometimes mistaken for less serious conditions like hemorrhoids or irritable bowel syndrome.
This diagnostic delay can contribute to later-stage detection, which affects treatment outcomes. While advancements in surgical techniques, radiation therapy, and targeted therapies have improved survival rates for colorectal cancer early detection remains critical for optimal prognosis. Health professionals are urging younger adults to not dismiss persistent gastrointestinal symptoms and to seek medical evaluation when concerns arise.
Public Health Response and Screening Considerations
In response to the rising incidence, some medical organizations are reevaluating screening strategies for younger populations. The U.S. Preventive Services Task Force currently recommends colorectal cancer screening starting at age 45 for adults at average risk, a guideline updated in 2021 from the previous starting age of 50. However, given the trend in early-onset cases, there is ongoing discussion about whether further adjustments to screening age or risk-based approaches might be warranted for certain high-risk groups.
Public awareness campaigns are also being expanded to educate both patients and healthcare providers about the symptoms of colorectal cancer in younger adults. Efforts include improving recognition of early warning signs, reducing stigma around discussing bowel health, and promoting timely follow-up for persistent gastrointestinal issues. Organizations such as the American Cancer Society and the Colorectal Cancer Alliance continue to provide resources on prevention, screening, and treatment options.
Researchers at institutions including SUNY Upstate Medical University, Dana-Farber Cancer Institute, and others are calling for increased funding and longitudinal studies to better understand the etiology of early-onset rectal cancer. They emphasize the importance of collecting data on lifestyle exposures, family history, and molecular tumor characteristics to identify potential prevention strategies.
As of April 23, 2026, the findings from the SUNY Upstate-led study are scheduled for formal presentation at Digestive Disease Week in San Diego, California, taking place from May 21–24, 2026. The annual meeting, organized by the American Gastroenterological Association, brings together thousands of gastroenterologists and hepatologists to share the latest advances in digestive disease research.
While the study has not yet undergone peer review, its authors note that the data aligns with broader national trends observed in cancer registries and epidemiological studies. They recommend that individuals experiencing persistent rectal bleeding, changes in stool consistency, or unexplained abdominal pain consult a healthcare provider regardless of age, as early evaluation can significantly impact diagnostic timelines and treatment outcomes.
For those seeking more information about colorectal cancer prevention, screening guidelines, or support resources, the National Cancer Institute and the Centers for Disease Control and Prevention offer evidence-based materials tailored to different age groups and risk levels.
Stay informed about developments in cancer research and public health by following updates from major medical conferences and peer-reviewed journals. Share this article to facilitate raise awareness about the importance of recognizing symptoms and seeking timely care.